Publicidad
Artículo original 31 de julio de 2015

Análise dos resíduos de atividade na radiosinoviortese com HA-Sm153

Referenciar Imprimir Descargar PDF

Referencias

  1. Raymond N, Dansereau BM. Dose variance associated with calibration and administration of radiopharmaceuticals. Am J Heal Pharm 2001;58.
  2. IAEA-TECDOC-1228. Therapeutic applications of radiopharmaceuticals. 2001 (January 1999):18-22.
  3. Kampen W U, Brenner W, Czech N HE. Intraarticular application of unsealed beta-emitting radionuclides in the treatment course of inflammatory joint diseases. Curr Med Chem -Anti- Inflamm Anti-Allergy Agents 2002;1:77-87.
  4. Delbarre F, Cayla J, Menkes C, et al.Synoviorthesis with radioisotopes. Press Med 1968;76:1045–50.
  5. Thomas S, Gabriel MB, Assi PE, et al. Radioactive synovectomy with Yttrium 90 citrate in haemo- philic synovitis: Brazilian experience. Haemophilia 2011; 17:e211-e216.
  6. De la Corte Rodriguez H, Rodriguez Merchan EC, Jimenez Yuste V. Radiosynovectomy in hemophilia: quantification of its effectiveness through the assessment of 10 articular parameters. J Thromb Haemost 2011;9:928-35.
  7. Llinás A. The role of synovectomy in the management of a target joint. Haemophilia 2008;14(supl.3):177-80.
  8. Rodriguez-Merchan EC. Aspects of current management: orthopaedic surgery in haemophilia. Haemophilia 2012;18:8-16.
  9. Dos Santos MF, Vilar Furtado RN, Konai S, et al. Effectiveness of radiation synovectomy with samarium-153 particulate hydroxyapatite in rheumatoid arthritis patients with knee synovitis: a controlled randomized double-blind trial. Clinics (Sao Paulo) 2009;64:1187-93.
  10. Thomas S. Sinovectomia radioativa na sinovite crônica em hemofilia e em doença de Von Willebrand. Dissertação de Mestrado apresentada ao Programa de Pós-Graduação em Clínica Médica da Faculdade de Medicina da Universidade Federal do Rio de Janeiro, 2009.
  11. Thomas S, Mendes JD. Radioactive synovectomy with 90 yttrium and 153 samarium hydroxyapatite in haemophilic joints : preliminary study on radiation safety. Haemophilia 2013;19:632-6.
  12. STATGRAPHICS 6. Manual de usuario.
  13. Torres M, Ayra E, Albuerne O. Absorbed dose profiles for (32)P, (90)Y, (188)Re, (177)Lu, (153)Sm and (169)Er: radionuclides used in radiosynoviortheses treatment. Rev Esp Med Nucl 2009;28:188-92.
  14. Pérez H, Ernesto A, García ET, et al. Simulación con Monte Carlo para dosimetría geométrica de rodilla humana. Cienc Erg Sum 2010;17:51-60.
  15. Deutsch E, Brodack JW. Radiation synovectomy revisited. Eur J Nucl Med 1993;20:1113-27.
  16. Van der Zant FM. Radiation synovectomy of the ankle, knee and upper extremity joints. Doctoral Thesis, University of Utretch, The Netherlands; 2008.
  17. Thomas S, Gabriel MC, De Souza SA, et al. Yttrium-hydroxyapatite: a new therapeutic option for radioactive synovectomy in haemophilic synovitis. Haemophilia 2011;17:985-9.
  18. Turkmen C. Safety of radiosynovectomy in hemophilic synovitis : it is time re-evaluate! J Coagul Disord 2009;2:1.
  19. Calegaro, J.U; Machado, J; De Paula, J.C; De Almeida, J.S.C; Casularis L. Clinical evaluation after 1 year of 153-samarium hydroxyapatite synovectomy in patients with haemophilic arthropathy. Haemophilia 2009;15:240-6.
  20. Thomas S. Efetividade da radiossinoviortese na sinovite hemofílica comparando-se três diferentes radiofármacos: hidroxiapatita ítrio-90 e samário-153. Doutorado em Medicina (Radiologia), Universidade Federal do Rio de Janeiro, 2013.
  21. Portaria CNEN NN 3.05. Requisitos de segurança e proteção radiológica para serviços de medicina nuclear. 2013.